BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report released on Friday morning. The brokerage issued a sell rating on the medical technology company’s stock.

BIOLASE Stock Performance

NASDAQ BIOL opened at $0.01 on Friday. The business’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.03. BIOLASE has a fifty-two week low of $0.02 and a fifty-two week high of $1.94. The company has a market cap of $310,685.10, a P/E ratio of 0.00 and a beta of 0.67.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.